| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.19 | 6e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |